COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01822509
Brief Title: Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

First Submitted : April 1, 2013
First Submitted that Met QC Criteria : April 1, 2013
First Posted : April 2, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : December 24, 2020
Last Update Posted : December 28, 2020